Plasma caveolin-1 to predict disease reclassification in men with early stage prostate cancer in active surveillance.
2016
5052Background: Given the morbidities of and limited tumor tissue from prostate biopsies (BXs), circulating biomarkers distinguishing indolent from aggressive disease and predicting disease reclass...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI